Nasopharyngeal carcinoma (NPC) is a malignancy arising from the nasopharyngeal mucosa [1]. This malignancy demonstrates a notable geographical variation in incidence, being highly prevalent in regions such as South China, Southeast Asia, and North Africa, where incidence rates range from 10 to 30 per 100,000 individuals annually [2]. Radiotherapy, particularly intensity-modulated radiation therapy (IMRT), is a critical and highly effective treatment for NPC, significantly improving survival outc…